Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04622878
Other study ID # Combined Management in ALI
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 1, 2020
Est. completion date December 31, 2021

Study information

Verified date November 2020
Source Assiut University
Contact kerolos Raafat khalil Gad Basta, resident
Phone 00201223548723
Email kerolosbasta93@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Acute limb ischemia (ALI) is a sudden decrease in limb perfusion due to either an embolic or a thrombotic vascular occlusion, defined as the presence of symptoms within two weeks of onset. The profound ischemia represents an emergency in which delayed treatment results in limb loss and, potentially, death. Therefore, timely diagnosis and proper treatments for ALI are important. Both surgical thrombectomy and endovascular treatment have benefits and drawbacks. Surgical thrombectomy using Fogarty embolectomy catheter has been the standard therapy because it is rapid and effective in cases of embolic ALI. However, blind surgical thrombectomy can result in poor revascularization or unexpected vascular injury in the presence of underlying arterial atherosclerosis or in the presence of subacute and chronic thrombi. In addition, thrombosis of runoff vessels is difficult to remove. Endovascular management using catheter-directed thrombolysis (CDT) has emerged as an alternative to surgery. It is less invasive, and does not directly damage the vascular endothelium with the capacity to clear thrombus in the small vessels. However, long treatment duration may worsen the clinical situation. Besides, a thrombus of more than two weeks does not respond well to the thrombolysis, and it is difficult to determine the exact stage of thrombus according to the clinical history. These problems may be minimized by combined treatment, which includes surgical thrombectomy and endovascular treatment.


Description:

The aim of our research is to evaluate the effectiveness and safety of combined treatment (surgical thrombectomy and endovascular treatment) for ALI with various clinical considerations


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date December 31, 2021
Est. primary completion date December 1, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients with acute onset of lower limb pain with various degrees of movement compromise. - History of intermittent claudication with a sudden worsening of claudication and pain at rest for less than one month. - Patients with Duplex or MSCT angiography of the lower limbs showing embolic events on healthy vessels or thrombosis of diseased vessels with or without collateralization. - Thrombus in a poor location that is difficult to be removed by surgical thrombectomy alone. - Acute lower limb ischemia due to acute arterial graft occlusion Exclusion Criteria: - - Medically compromised patients, not fit for the intervention. - Patients with critical chronic limb ischemia (grade III, IV). - Patients with known vasculitis or lab investigations suggesting vasculitis before treating the cause. - Patients who refused the intervention.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
thrombectomy and PTA
open femoral access with fogarty catheter then PTA with balloon and possible stenting if needed

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (2)

Kashyap VS, Gilani R, Bena JF, Bannazadeh M, Sarac TP. Endovascular therapy for acute limb ischemia. J Vasc Surg. 2011 Feb;53(2):340-6. doi: 10.1016/j.jvs.2010.08.064. Epub 2010 Nov 3. — View Citation

Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997 Sep;26(3):517-38. Erratum in: J Vasc Surg 2001 Apr;33(4):805. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary limb salvage Technical success rates is defined as patency of the treated vessel segment with less than 20 % residual stenosis , without dissection and restoration of in line flow to foot , weight and height of the pt will be combined to report BMI kg/m^2 immediately post operative
See also
  Status Clinical Trial Phase
Completed NCT05411315 - Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment N/A
Completed NCT04066387 - Characteristics and Prognosis of Patients With Critical Ischemia at High Risk of Amputation Managed by Endovascular Bypass: a Retrospective Study of 15 Patients
Completed NCT00453531 - Model System for Transient Forearm Blood Vessel Dysfunction Phase 1/Phase 2
Completed NCT00730561 - Hematopoietic Stem Cell Transplantation for the Treatment of Limb Ischemia and Diabetic Neuropathy N/A
Completed NCT05410548 - Comorbidity Screening and Referral by Prosthetists N/A
Enrolling by invitation NCT06229015 - Evaluation of Online Tool (E-TOOL SCS) in Spinal Cord Stimulaion
Recruiting NCT05830721 - Continuous Compartment Pressure Monitoring for Compartment Syndrome in VA-ECMO Patients N/A
Completed NCT04016857 - Remote Ischemic Preconditioning During Lower Limb Revascularization N/A
Active, not recruiting NCT04466007 - Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia Phase 2
Recruiting NCT06050499 - Chemical Analysis of Limb Microfluidics
Recruiting NCT03040063 - Complex Endovascular Approach to Treatment of Patients With Aneurysm of Popliteal Artery N/A
Completed NCT04343196 - Digital Variance Angiography in Diagnostic Angiographies for Effective Radiation Dose Reduction N/A
Not yet recruiting NCT06357936 - Nanofat Grafting as a Method of Treating Critical Limb Ischemia N/A